Biomarkers, Validation and Pharmacokinetic-Pharmacodynamic Modelling

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.42, Iss.12, 2003-01, pp. : 997-1022

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetic/Pharmacodynamic Modelling in Diabetes Mellitus

By Landersdorfer Cornelia B. Jusko William J.

Clinical Pharmacokinetics, Vol. 47, Iss. 7, 2008-01 ,pp. : 417-448

Adis International

Access to resources Recommend Favorite

Methodological Issues in Pharmacokinetic-Pharmacodynamic Modelling

By Bellissant E.

Clinical Pharmacokinetics, Vol. 35, Iss. 2, 1998-08 ,pp. : 151-166

Adis International

Access to resources Recommend Favorite

Gene Therapy: A Pharmacokinetic/Pharmacodynamic Modelling Overview

By Parra-Guillén Zinnia González-Aseguinolaza Gloria Berraondo Pedro Trocóniz Iñaki

Pharmaceutical Research, Vol. 27, Iss. 8, 2010-08 ,pp. : 1487-1497

Springer Publishing Company

Access to resources Recommend Favorite

Validation of a population pharmacokinetic/pharmacodynamic model for 5 -reductase inhibitors

By Trouw R.A.J. De Wit M.J. Olsson Gisleskog P. Hermann D. Hammarlund-Udenaes M. Karlsson M.O.

European Journal of Pharmaceutical Sciences, Vol. 8, Iss. 4, 1999-08 ,pp. : 291-299

Elsevier

Access to resources Recommend Favorite

Population Pharmacokinetic/Pharmacodynamic Modelling of the Analgesic Effects of Tramadol in Pediatrics

By Garrido María Habre Walid Rombout Ferdinand Trocóniz Iñaki

Pharmaceutical Research, Vol. 23, Iss. 9, 2006-09 ,pp. : 2014-2023

Springer Publishing Company

Access to resources Recommend Favorite